Plerixafor effectively rescues biosimilar G-CSF-alone-based stem cell mobilisation failures

Autor:	Shab Uddin, Andrew J. Innes, J. F. Apperley, Sandra Loaiza, M. Atta, Edward Kanfer, Syed Y Altaf, Sara Lozano, Renuka Palanicawandar, Eduardo Olavarria, Oscar M. Pello, Belen Sevillano, Ahmad Khoder, Anne Bradshaw, Jiri Pavlu, M. Sever, E. Bray, Silvia Monsalvo, V. Selvaratnam, Holger W. Auner
Rok vydání:	2017
Předmět:	Cancer Research Transplantation business.industry Plerixafor Immunology Biosimilar Cell Biology Pharmacology Stem cell mobilisation Oncology Immunology and Allergy Medicine business Genetics (clinical) medicine.drug
Zdroj:	Cytotherapy. 19:S77
ISSN:	1465-3249
DOI:	10.1016/j.jcyt.2017.02.123
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2cb5185ca4fd1300a24fd6ef52285e91 https://doi.org/10.1016/j.jcyt.2017.02.123 Zobrazit plný text záznamu Full Text from ScienceDirect